Neumora Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 200, Watertown, MA

Insiders trading volume in the past year

Neumora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amgen Inc 10%+ Owner $424M Sep 19, 2023
Kristina Burow Director, 10%+ Owner $383M Feb 13, 2025
ARCH Venture Partners X, LLC 10%+ Owner $383M Dec 8, 2023
ARCH Venture Partners XII, LLC 10%+ Owner $383M Dec 8, 2023
Fmr Llc Other* $67.4M Sep 19, 2023
Paul L. Berns Title: Chief Executive Officer and Chairman of the Board, Director $12.8M -$23.5K -0.18% Feb 18, 2025
Henry O. Gosebruch President & CEO, Director $7.07M Feb 14, 2024
Carol Y. Suh Chief Operating Officer $4.49M Feb 14, 2024
Robert A. Lenz Head of R&D $517K -$1.09M -67.8% Feb 18, 2025
Joshua Pinto President $362K -$1.18M -76.5% Feb 18, 2025
Matthew K. Fust Director $342K -$371K -52% Feb 13, 2025
Daljit Singh Aurora Chief Strategy Officer $341K -$14.3K -4.04% Feb 18, 2025
Maykin Ho Director $241K Feb 13, 2025
David Piacquad Director $241K Feb 13, 2025
Alaa Halawa Director $241K Feb 13, 2025
Michael Milligan Title: Chief Financial Officer & Principal Accounting Officer $38.1K -$3.35K -8.09% Feb 18, 2025
Jason Duncan Title: Chief Legal and Administrative Officer Feb 13, 2025

Recent Insider Transactions by Companies or Individuals for Neumora Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.